To obtain direct evidence for the involvement of the RAS-RAF-MEK-ERK and PI3K-AKT/PKB-mTOR pathways in increasing the resistance of gliomas to the induction of programmed cell death by chemotherapeutics, we blocked the expression of RAF and PI3K kinases by specific siRNAs. Here, AKT1 is linked to central nervous system cancer.